Clinical data management is entering a new phase as AI automates EDC build, shortens timelines, and enables data teams to focus on quality.

Interim observations from the Phase 2 TRAILHEAD study show continued improvement in handgrip strength, overall stability of elbow and shoulder strength in new dynamometry measurements Greater ...

Strategic partnership eliminates human error and provides sponsors with real-time, high-quality clinical data for critical ...

The partnership connects structured clinical data with EHR workflows to accelerate referrals, care coordination, and ...

Jonathan Andrus, co-CEO of CRIO, discusses how increased reliance on site-based technologies and eSource is strengthening ...

Q4 2025 earnings call recap: pipeline milestones, PROTAC FDA/PDUFA timeline, 2026 data catalysts, and cash runway—read now.

For sura-vec in wet AMD, top line data from pivotal studies ATMOSPHERE and ASCENT are anticipated in Q4. First patient dosing in NAVIGATE for diabetic retinopathy is planned next quarter, expected to ...

Cullinan Therapeutics (NASDAQ:CGEM) executives highlighted upcoming clinical milestones for the company’s two high-priority T-cell engager programs during remarks at the 46th Annual TD Cowen ...

Investor attention is turning to Tvardi Therapeutics as the biopharmaceutical company approaches several significant clinical data readouts in the first half of ...

As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships align to support both speed and sustainability. The shift toward hybrid models, ...

OmniMD introduces a unified AI-powered clinical–financial platform delivering predictive revenue insights, automation, ...